Plain-English translation of NCT06597695 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Depression research guide โPhase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is an early-stage research study testing a new approach to treating depression in Spanish-speaking adults. The study combines ketamine, a medication that researchers believe may help with depression symptoms, with group therapy sessions where participants meet together with a trained therapist. The researchers want to learn if this combined treatment is safe, feasible to deliver, and effective.
Many people with depression don't get relief from standard antidepressant medications, and treatment options are especially limited for Spanish-speaking communities. This medication has shown promise in recent research for helping people with severe depression, and this study aims to see if adding group therapy can make the treatment even more effective and culturally supportive.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive ketamine as a medication while participating in group therapy sessions with other Spanish-speaking adults who have depression. The exact schedule of visits and duration isn't fully detailed here, but you would need to have an existing psychiatrist and primary care doctor overseeing your care. This is a small pilot study enrolling about 10 people total, so you'd be part of an intimate group learning together about this new treatment approach.
AI-generated summary from trial data ยท Oct 3, 2026 ยท Not medical advice
United States